Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 14Lung Neoplasms 10Colonic Neoplasms 10Breast Neoplasms 9Brain Neoplasms 6Prostatic Neoplasms 4Emergence Delirium 4Urinary Bladder Neoplasms 3Stomach Neoplasms 3Respiratory Aspiration 3Rectal Neoplasms 3Pituitary Neoplasms 3Neoplastic Cells, Circulating 3Hypoxia 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Agnosia 3Supratentorial Neoplasms 2Postoperative Complications 2Patient Satisfaction 2Pain, Postoperative 2Pain 2Ovarian Neoplasms 2Melanoma 2Liver Neoplasms 2Leukemia 2Delirium 2Colorectal Neoplasms 2Uterine Neoplasms 1Tuberculosis, Pulmonary 1

Interventions

alfatide II 1Propofol 1Fluorodeoxyglucose F18 1Alfentanil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Tuberculosis, Pulmonary × Propofol × Clear all
NCT07395596 2026-02-24

Remimazolam for Bronchoscopy in High-Risk Patients

First Affiliated Hospital of Zhejiang University

Phase 4 Recruiting
360 enrolled

Hypoxia, Tuberculosis, Pulmonary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡